The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Metformin as adjunct antituberculosis therapy
Abstract
The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential new approach to TB therapy is to augment protective host immune responses. We report that the antidiabetic drug metformin (MET) reduces the intracellular growth of Mycobacterium tuberculosis (Mtb) in an AMPK (adenosine monophosphate-activated protein kinase)-dependent manner. MET controls the growth of drug-resistant Mtb strains, increases production of mitochondrial reactive oxygen species, and facilitates phagosome-lysosome fusion. In Mtb-infected mice, use of MET ameliorated lung pathology, reduced chronic inflammation, and enhanced the specific immune response and the efficacy of conventional TB drugs. Moreover, in two separate human cohorts, MET treatment was associated with improved control of Mtb infection and decreased disease severity. Collectively, these data indicate that MET is a promising candidate host-adjunctive therapy for improving the effective treatment of TB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the anti-diabetic drug metformin is being utilized an immunomodulator for tuberculosis (Singhal et al., 2014).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Singhal et al., 2014
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,328
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Tlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659
Transcriptional control of effector and memory CD8+ T cell differentiation
Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,194
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Unveiling the roles of autophagy in innate and adaptive immunity
Levine, B., & Deretic, V. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2161 · Cited by 934
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A. I., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 921
Salminen, A., Hyttinen, J. M. T., & Kaarniranta, K. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0748-0 · Cited by 866
PAGE: Parametric Analysis of Gene Set Enrichment
Kim, S., & Volsky, D. J. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-144 · Cited by 777
Mitochondria-Ros Crosstalk in the Control of Cell Death and Aging
Marchi, S., Giorgi, C., Suski, J. M., Agnoletto, C., Bononi, A., Bonora, M., Marchi, E. D., Missiroli, S., Patergnani, S., Poletti, F., et al. (2011) · Journal of Signal Transduction · doi:10.1155/2012/329635 · Cited by 658
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?
Behar, S. M., Divangahi, M., & Remold, H. G. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2387 · Cited by 427
Molecular Epidemiology of Tuberculosis: Current Insights
Mathema, B., Kurepina, N. E., Bifani, P. J., & Kreiswirth, B. N. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00061-05 · Cited by 415
Self-citationChemical modulators of autophagy as biological probes and potential therapeutics
Fleming, A., Noda, T., Yoshimori, T., & Rubinsztein, D. C. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.500 · Cited by 358
Kumar, D., Nath, L., Kamal, M. A., Varshney, A., Jain, A., Singh, S., & Rao, K. V. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.012 · Cited by 347
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1
Kuijl, C. P., Savage, N. D. L., Marsman, M., Tuin, A. W., Janssen, L., Egan, D. A., Ketema, M., van den Nieuwendijk, R., van den Eeden, S. J. F., Geluk, A., et al. (2007) · Nature · doi:10.1038/nature06345 · Cited by 306
Host Innate Immune Response to Mycobacterium tuberculosis
Bhatt, K., & Salgame, P. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9084-0 · Cited by 223
Vilaplana, C., Marzo, E., Tapia, G., Diaz, J., Garcia, V., & Cardona, P.-J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit152 · Cited by 220
Synthetic EthR inhibitors boost antituberculous activity of ethionamide
Willand, N., Dirié, B., Carette, X., Bifani, P. J., Singhal, A., Desroses, M., Leroux, F., Willery, E., Mathys, V., Deprez-Poulain, R. F., et al. (2009) · Nature Medicine · doi:10.1038/nm.1950 · Cited by 187
Self-citationEvasion and subversion of antigen presentation by Mycobacterium tuberculosis
Baena, A., & Porcelli, S. A. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01301.x · Cited by 148
Estimating the starting dose for entry into humans: principles and practice
Reigner, B. G., & Blesch, K. S. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-001-0405-6 · Cited by 132
Host-Directed Drug Targeting of Factors Hijacked by Pathogens
Schwegmann, A., & Brombacher, F. (2008) · Science Signaling · doi:10.1126/scisignal.129re8 · Cited by 129
Murray, R. A., Mansoor, N., Harbacheuski, R., Soler, J., Davids, V., Soares, A. P., Hawkridge, A., Hussey, G. D., Maecker, H. T., Kaplan, G., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.5647 · Cited by 100
Self-citationSubbian, S., Tsenova, L., O’Brien, P. E., Yang, G., Koo, M.-S., Peixoto, B., Fallows, D. A., Dartois, V. A., Muller, G. W., & Kaplan, G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002262 · Cited by 94
Self-citationCommandeur, S., Lin, M. Y., van Meijgaarden, K. E., Friggen, A. H., Franken, K. L. M. C., Drijfhout, J. W., Korsvold, G. E., Oftung, F., Geluk, A., & Ottenhoff, T. H. M. (2011) · European Journal of Immunology · doi:10.1002/eji.201141602 · Cited by 92
Subbian, S., Tsenova, L., O’Brien, P. E., Yang, G., Koo, M.-S., Peixoto, B., Fallows, D. A., Zeldis, J. B., Muller, G. W., & Kaplan, G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.039 · Cited by 89
Self-citationLyadova, I. V., Eruslanov, E. B., Khaidukov, S. V., Yeremeev, V., Majorov, K. B., Pichugin, A. V., Nikonenko, B. V., Kondratieva, T. K., & Apt, A. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5921 · Cited by 76
Adjunct Immunotherapies for Tuberculosis
Uhlin, M., Andersson, J., Zumla, A. I., & Maeurer, M. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis197 · Cited by 76
Koo, M.-S., Manca, C., Yang, G., O’Brien, P. E., Sung, N., Tsenova, L., Subbian, S., Fallows, D. A., Muller, G. W., Ehrt, S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017091 · Cited by 75
Self-citationThe Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing World
Sullivan, T., & Amor, Y. B. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001269 · Cited by 71
Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice
Chackerian, A. A., & Behar, S. M. (2003) · Tuberculosis · doi:10.1016/s1472-9792(03)00017-9 · Cited by 68
Maïga, M., Ammerman, N. C., Maiga, M. C., Tounkara, A., Siddiqui, S., Polis, M., Murphy, R. L., & Bishai, W. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit187 · Cited by 56
Middelkoop, K., Bekker, L., Mathema, B., Shashkina, E., Kurepina, N. E., Whitelaw, A. C., Fallows, D. A., Morrow, C. D., Kreiswirth, B. N., Kaplan, G., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/605930 · Cited by 54
Self-citationClonal Expansion of CD8+ Effector T Cells in Childhood Tuberculosis
Jacobsen, M., Detjen, A., Mueller, H., Gutschmidt, A., Schommer-Leitner, S., Wahn, U., Magdorf, K., & Kaufmann, S. H. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1331 · Cited by 44
Kumar, D., & Rao, K. V. S. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.10.009 · Cited by 39
Setting new targets in the fight against tuberculosis
Raviglione, M. C., & Diţiu, L. (2013) · Nature Medicine · doi:10.1038/nm.3129 · Cited by 28
Zumla, A. I., & Maeurer, M. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir881 · Cited by 22
Host-directed therapies against tuberculosis
Wilkinson, R. J. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70295-9 · Cited by 14
Ahead of WHO meeting, experts clash over tuberculosis targets
Maxmen, A. (2013) · Nature Medicine · doi:10.1038/nm0213-115 · Cited by 8
Cited by
Sorted by citations
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Sun, L., Xie, C., Wang, G., Wu, Y., Wu, Q., Wang, X., Liu, J., Deng, Y., Xia, J., Chen, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0222-4 · Cited by 1,011
Mitochondria in the Regulation of Innate and Adaptive Immunity
Weinberg, S. E., Sena, L. A., & Chandel, N. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.002 · Cited by 960
Arts, R. J. W., Novakovic, B., ter Horst, R., Carvalho, A., Bekkering, S., Lachmandas, E., Rodrigues, F., Silvestre, R., Cheng, S.-C., Wang, S.-Y., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.008 · Cited by 930
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. F. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 869
Metformin: update on mechanisms of action and repurposing potential
Foretz, M., Guigas, B., & Viollet, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00833-4 · Cited by 791
Metadata
- Authors
- Singhal, A., Jie, L., Kumar, P., Hong, G. S., Leow, M. K.-S., Paleja, B., Tsenova, L., Kurepina, N., Chen, J., Zolezzi, F., Kreiswirth, B., Poidinger, M., Chee, C., Kaplan, G., Wang, Y. T., & De Libero, G.
- Affiliations
- Agency for Science, Technology and Research (SG)
- Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.
- Tan Tock Seng Hospital (SG)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Singhal, Amit
- Kumar, Pavanish
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2014-11-19
- Volume
- 6
- Issue
- 263
- Pages
- 263ra159-263ra159
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2105296171
- Cited by
- 547
- References
- 49
- Citations by year
- 2026: 39 · 2025: 44 · 2024: 44 · 2023: 35 · 2022: 51 · 2021: 64 · 2020: 71 · 2019: 53 · 2018: 51 · 2017: 33 · 2016: 35 · 2015: 24 · 2014: 2
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- edoc (University of Basel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- metformin, tuberculosis, Mycobacterium tuberculosis, AMPK, host-directed therapy, drug-resistant tuberculosis, reactive oxygen species, phagosome-lysosome fusion, host immune response, chronic inflammation
- MeSH terms
- Humans, Metformin, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Tuberculosis, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review